Press release
Enhancing Cancer Care: Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market to Grow at CAGR of 7.5% by 2033
Chemotherapy Induced Nausea And Vomiting (CINV) Drugs Market
Market Size & Insights
The CINV drugs market has grown significantly as supportive oncology care becomes a central focus in cancer treatment. The chemotheraphy induced nausea and vomitting (CINV) drugs market is valued at approximately USD 3.09 billion in 2024 and is anticipated to reach around USD 5.88 billion by 2033. Chemotherapy, while effective in cancer management, is often associated with debilitating side effects such as nausea and vomiting. This creates an essential demand for antiemetic therapies that ensure patients continue their treatment without severe discomfort.
CINV drugs primarily include serotonin receptor antagonists (5-HT3 RAs), neurokinin-1 receptor antagonists (NK1 RAs), dopamine antagonists, corticosteroids, and combination therapies. These agents have evolved to target both acute and delayed phases of nausea and vomiting, significantly improving patient compliance.
The adoption of novel drug delivery systems, long-acting formulations, and biosimilars is shaping market growth. Increasing awareness among healthcare providers and patients about supportive care has further boosted demand. Additionally, the expansion of oncology treatment centers in emerging economies and the growing use of personalized medicine approaches are contributing to market expansion. As cancer incidences continue to rise globally, the role of CINV drugs in ensuring treatment continuity will become more critical.
Get a free sample report: https://datahorizzonresearch.com/request-sample-pdf/chemotheraphy-induced-nausea-and-vomitting-cinv-drugs-market-4647
Important Points
• Rising global cancer prevalence fueling demand for supportive care drugs.
• Increasing adoption of combination therapies for enhanced efficacy.
• Expansion of oncology treatment centers in developing regions.
• Growing use of biosimilars and cost-effective generics.
• Advancements in drug delivery mechanisms ensuring prolonged relief.
• Focus on patient-centric oncology care improving quality of life.
Key Factors Driving the Future Growth of the CINV Drugs Market
• Cancer Burden: Rising incidence of cancer globally requiring effective supportive drugs.
• Innovation in Therapies: Development of novel receptor antagonists with superior efficacy.
• Patient Adherence: Improved symptom management ensuring continuation of chemotherapy cycles.
• Healthcare Expansion: Growth of oncology centers in Asia-Pacific and Latin America.
• Regulatory Support: Faster approvals for supportive care drugs enhancing accessibility.
• Precision Medicine: Personalized treatments boosting tailored drug combinations.
Top 10 Market Companies
• Merck & Co., Inc.
• Novartis AG
• GlaxoSmithKline plc
• Bristol-Myers Squibb Company
• Pfizer Inc.
• Helsinn Healthcare SA
• Heron Therapeutics, Inc.
• Tesaro, Inc. (GSK)
• Dr. Reddy's Laboratories Ltd.
• Cipla Ltd.
Market Segments
By Drug Class
o 5-HT3 Receptor Antagonists
o NK-1 Receptor Antagonists
o Dopamine Antagonists
o Corticosteroids
o Others
By Route of Administration
o Oral
o Intravenous (IV)
o Transdermal
o Others
By End-Use
o Hospitals
o Oncology Clinics
o Home Care Settings
o Others
By Region:
o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa
Recent Developments
• Launch of next-generation NK1 receptor antagonists with improved efficacy.
• Expansion of biosimilar portfolios targeting cost-sensitive markets.
• Strategic collaborations between pharma companies and cancer research centers.
• Introduction of long-acting injectable formulations for better compliance.
• Regulatory approvals for novel combination therapies in CINV management.
• Increasing investments in R&D for supportive oncology care drugs.
Regional Insights
North America dominates the CINV drugs market, supported by a strong oncology infrastructure, high healthcare spending, and rapid drug approvals. Europe follows, driven by growing awareness of supportive care and government-backed cancer management programs. The Asia-Pacific region is projected to record the fastest growth, fueled by rising cancer incidence, expanding healthcare infrastructure, and increasing adoption of biosimilars. Latin America and the Middle East are also emerging as promising markets due to expanding oncology treatment accessibility and growing pharmaceutical investments.
Market Outlook
The outlook for the CINV drugs market is highly positive, as supportive care becomes increasingly integral to cancer treatment regimens. With oncology therapies advancing rapidly, effective symptom management is essential to ensure treatment success and improve quality of life for patients.
Over the forecast period, the market will witness growing adoption of biosimilars, generics, and cost-effective drug formulations, making therapies more accessible in developing countries. Simultaneously, the demand for advanced combination therapies in developed regions will rise, offering patients comprehensive protection from both acute and delayed nausea.
Technological advancements in drug delivery, such as sustained-release injectables and transdermal patches, will further enhance compliance. Moreover, ongoing research into novel receptor targets and the integration of personalized medicine approaches are expected to create new growth opportunities.
By 2033, the CINV drugs market is projected to become a cornerstone of global oncology care, ensuring that patients can undergo life-saving treatments with reduced discomfort and improved adherence, ultimately supporting better survival outcomes and enhanced well-being.
Contact:
Ajay N
Ph: +1-970-633-3460
Latest Reports:
Acoustic Cabinets Market: https://datahorizzonresearch.com/acoustic-cabinets-market-52762
Acoustic Furniture Market: https://datahorizzonresearch.com/acoustic-furniture-market-52763
Acrylic Paint Marker Pens Market: https://datahorizzonresearch.com/acrylic-paint-marker-pens-market-52764
Acrylic Painting Frame Market: https://datahorizzonresearch.com/acrylic-painting-frame-market-52765
Company Name: DataHorizzon Research
Address: North Mason Street, Fort Collins,
Colorado, United States.
Mail: sales@datahorizzonresearch.com
DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR's comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enhancing Cancer Care: Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market to Grow at CAGR of 7.5% by 2033 here
News-ID: 4185023 • Views: …
More Releases from DataHorizzon Research
Dabigatran Etexilate Capsules Market to Grow Strongly by 2033, Anticipated to Ex …
According to a new study by DataHorizzon Research, the Dabigatran Etexilate Capsules Market is projected to grow at a CAGR of 13.61% from 2025 to 2033, driven by the rising global burden of cardiovascular diseases, increasing cases of atrial fibrillation, and growing preference for novel oral anticoagulants (NOACs) over traditional therapies. Dabigatran Etexilate-an established direct thrombin inhibitor-has gained wide adoption due to its strong efficacy profile, predictable pharmacokinetics, and reduced…
Climbing Shoes Market to Register Strong Growth by 2033, Expected to Expand at a …
According to a new study by DataHorizzon Research, the Climbing Shoes Market is projected to grow at a CAGR of 5.4% from 2025 to 2033, driven by rising global participation in outdoor sports, the rapid expansion of indoor climbing gyms, and growing interest in adventure tourism. Climbing shoes-designed to enhance grip, toe strength, and precision-are becoming increasingly popular among beginners and professionals as climbing evolves into a mainstream sport. The…
Global Li6 and Li7 Market to Witness Strong Growth by 2033, Expected to Expand a …
According to a new study by DataHorizzon Research, the Global Li6 and Li7 Market is projected to grow at a CAGR of 8.4% from 2025 to 2033, driven by the rising demand for advanced nuclear technologies, growing need for enriched lithium isotopes, and increasing applications across energy storage, defense systems, medical imaging, and fusion research. With global energy systems transitioning toward next-generation nuclear and clean energy solutions, Li6 and Li7…
Royalty and Rights Management Software Market to Expand Strongly by 2033, Expect …
According to a new study by DataHorizzon Research, the Royalty and Rights Management Software Market is projected to grow at a CAGR of 8.2% from 2025 to 2033, driven by the rising complexity of content monetization, growing digital media consumption, and the increasing need for automated rights tracking across publishing, entertainment, sports, and licensing industries. As global content creation accelerates-from music and films to digital art and gaming-organizations are rapidly…
More Releases for CINV
Rising Cancer Prevalence Spurs Growth In The Chemotherapy-Induced Nausea And Vom …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market encompassing chemotherapy-induced nausea and vomiting treatments has witnessed substantial expansion, projected to increase its valuation from $2.92 billion in 2024 to $3.13 billion in 2025, reflecting a compound annual growth…
CINV Treatment Market to Reach USD 3.9 Billion by 2034
Pune, India, November 11, 2025 - The global Chemotherapy-Induced Nausea and Vomiting (CINV) Treatment Market is projected to grow from USD 2.6 billion in 2024 to USD 3.9 billion by 2034, registering a CAGR of 4.1 %, according to Exactitude Consultancy. Rising cancer incidence, increasing chemotherapy adoption, and development of next-generation serotonin (5-HT3) and neurokinin-1 (NK1) receptor antagonists are driving global market expansion.
Download Full PDF Sample Copy of Market Report…
Emerging Trends Influencing The Growth Of The Chemotherapy-Induced Nausea and Vo …
The Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Expected to Be by 2034?
There has been a notable growth in the market size of chemotherapy-induced nausea and vomiting (CINV)…
Key Influencer in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market 202 …
How Are the key drivers contributing to the expansion of the chemotherapy-induced nausea and vomiting (cinv) market?
The escalating cases of cancer are expected to foster the expansion of the market for chemotherapy-induced nausea and vomiting (CINV). This rise is due to the uncontrolled development and spread of cancer cells in the body. As cancer prevalence increases, there's an increased drive to produce highly effective and specific anti-emetic treatments, which would…
CINV Existing and Pipeline Drugs Market: Rising Demand for CINV Drugs Owing to I …
CINV drugs are administered to patients suffering from vomiting and nausea that occurs as a side effect of chemotherapy. CINV can hinder the progress of patients undergoing chemotherapy, making it very crucial for oncologists to prescribe the right kind of CINV drugs to alleviate the discomfort. Delayed CINV and acute CINV are the two major subtypes of this condition. While the former occurs up to five days after treatment, the…
CINV Existing and Pipeline Drugs Market : Growing number of patients undergoing …
The growth of the global chemotherapy induced nausea and vomiting (CINV) market will be steered by the growing number of patients undergoing chemotherapy and a number of new drugs expected to be approved in the near future, says Transparency Market Research. In its report, titled “CINV Existing and Pipeline Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,” the business intelligence firm says that…
